Species differences in carcinogenicity: The role of metabolism in human risk evaluation
- 1 January 1990
- journal article
- review article
- Published by Wiley in Teratogenesis, Carcinogenesis, and Mutagenesis
- Vol. 10 (2), 103-113
- https://doi.org/10.1002/tcm.1770100206
Abstract
The assessment of human risk from exposure to chemicals is frequently confounded by differences in response to those chemicals in laboratory animals. In many cases, the basis of the species differences is differences in metabolism and pharmacokinetics. Since metabolic and pharmacokinetic data are readily accessible in both laboratory animals and humans, risk assessments can be significantly improved if these data are incorporated into the process. Several chlorinated solvents, perchloroethylene, trichloroethylene, and methylene chloride, have been investigated, and the species differences in carcinogenicity have been shown to be the result of pharmacokinetic differences between the species. The rates of metabolism of these chemicals have been measured in rats and mice in vivo, and the species differences observed have been reproduced in vitro using tissue fractions and hepatocytes. Identical experiments have been carried out using human tissues. The results of these studies together with species‐specific physiological parameters have been used in a mathematical model to predict human cancer risk over a wide range of exposures. This approach provides both an explanation for the species differences in response to these chemicals and also a more rational approach to human risk assessment.Keywords
This publication has 25 references indexed in Scilit:
- Perchloroethylene-induced rat kidney tumors: An investigation of the mechanisms involved and their relevance to humansToxicology and Applied Pharmacology, 1990
- Physiologically based pharmacokinetic model for vinylidene chlorideToxicology and Applied Pharmacology, 1988
- The role of trichloroacetic acid and peroxisome proliferation in the differences in carcinogenicity of perchloroethylene in the mouse and ratToxicology and Applied Pharmacology, 1988
- Identification of S‐1,2,2‐trichlorovinyl‐N‐acetylcysteine as a urinary metabolite of tetrachloroethylene: Bioactivation through glutathione conjugation as a possible explanation of its nephrocarcinogenicityJournal of Biochemical Toxicology, 1986
- Metabolism of inhaled dihalomethanes in vivo: Differentiation of kinetic constants for two independent pathwaysToxicology and Applied Pharmacology, 1986
- Species differences in response to trichloroethyleneToxicology and Applied Pharmacology, 1985
- Species differences in response to trichloroethyleneToxicology and Applied Pharmacology, 1985
- Structure/activity studies of the nephrotoxic and mutagenic action of cysteine conjugates of chlgro and fluoroalkenesChemico-Biological Interactions, 1985
- A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humansToxicology and Applied Pharmacology, 1984
- Methylene chloride: A two-year inhalation toxicity and oncogenicity study in rats and hamsters*1Fundamental and Applied Toxicology, 1984